WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.
about
A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantationWR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects.Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II studyExposure of human ovarian carcinoma to cisplatin transiently sensitizes the tumor cells for liposome-mediated gene transfer.Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy.DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications.p53 protein regulates the effects of amifostine on apoptosis, cell cycle progression, and cytoprotection.Annexin a5 as a new potential biomarker for Cisplatin-induced toxicity in human kidney epithelial cells.Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models.In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype.Comparison of the cytotoxic effects of Juniperus sabina and Zataria multiflora extracts with Taxus baccata extract and Cisplatin on normal and cancer cell lines.In vitro effect of amifostine on haematopoietic progenitors exposed to carboplatin and non-alkylating antineoplastic drugs: haematoprotection acts as a drug-specific progenitor rescue.Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle.Cytotoxicity and cytoprotective activities of natural compounds. The case of curcumin.Vitamin E prevents UVB-induced cell blebbing and cell death in A431 epidermoid cells.Biochemical changes associated with ascorbic acid-cisplatin combination therapeutic efficacy and protective effect on cisplatin-induced toxicity in tumor-bearing mice.Comparison of the toxicities of cisplatin and a new cisplatin-procaine complex to rat renal cortical slices.A density functional reactivity theory (DFRT) based approach to understand the interaction of cisplatin analogues with protecting agents.N-acetyl-L-cysteine modulates the metabolism of cis-platin in human plasma in vitro.Activation of the cholinergic anti-inflammatory pathway by GTS-21 attenuates cisplatin-induced acute kidney injury in mice.Chemoprotection by D-methionine against cisplatin-induced side-effects: insight from in vitro studies using human plasma.Magnesium improves cisplatin-mediated tumor killing while protecting against cisplatin-induced nephrotoxicity.Histopathology of human temporal bone after cis-platinum, radiation, or both.
P2860
Q28346786-36C9E183-A83B-4037-9129-89361477EF50Q30492649-D3F6E9BF-60FD-43FE-A542-F9EF5A6629A3Q33494941-59A5F68D-FAED-4844-A7C6-AF398A24045DQ35997145-0569FADF-868A-4A17-AAD3-77BBB019292EQ36825081-F5E5475A-8D6A-472D-A045-40CE93EDAEEBQ37441359-2730C26C-C5CC-4BFA-8842-879EC4C0D53CQ38121955-5F89C2F3-4CEF-42E9-9572-C124CA0ACF84Q38293704-235972E3-BE69-49F2-8D74-13B58E8C6B44Q38444384-4AAB9B38-AB0D-48F6-A7E2-97BF98324C8CQ38962673-284F08D0-22F6-4A17-B0E6-F57A3746B6DDQ39455887-1B595EE4-FBB6-4BFB-A637-FF682D9DBE3CQ39674090-48B82EE4-0F3E-483C-BEFA-7415D5FA27A6Q39710489-3A7603C1-B8A4-450F-B6BB-A2CB9D8B8A65Q39806365-7B5F75B7-BAE6-46B0-94D5-A35FF0D72FA4Q41119927-BD640286-1306-4F33-954A-5DE55E871E77Q41653954-D49200E8-6ADC-432F-B142-421D439061DAQ41680511-DFEE1970-31F1-4BF0-B16B-0E610F87162AQ42553463-2A64BE16-45DC-40CF-80CD-F85DC829BB1EQ44770779-358AF50F-D63F-4F78-903C-865E5425CB7EQ45241480-701050EA-B948-47D5-9885-B13DAC4C2386Q46250983-4A4E7C23-8FCA-47BE-A5B6-925B127DC057Q46959686-5F9D19E2-D1ED-4FEC-A532-4019C88A3CD0Q47305361-520A7BB0-616A-40DA-82E5-3F4792F80B3FQ50505265-80315694-17EF-4D92-8E52-DDDC61F63332
P2860
WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
WR2721 as a modulator of cispl ...... agents: a molecular approach.
@en
type
label
WR2721 as a modulator of cispl ...... agents: a molecular approach.
@en
prefLabel
WR2721 as a modulator of cispl ...... agents: a molecular approach.
@en
P2860
P356
P1476
WR2721 as a modulator of cispl ...... agents: a molecular approach.
@en
P2093
W J van der Vijgh
P2860
P2888
P304
P356
10.1007/BF00685326
P577
1993-01-01T00:00:00Z
P6179
1027838024